BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, Korthuis PT. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis. J Gen Intern Med 2019;34:2796-803. [PMID: 31410816 DOI: 10.1007/s11606-019-05251-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Joudrey PJ, Oldfield BJ, Yonkers KA, O'Connor PG, Berland G, Edelman EJ. Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders. Drug Alcohol Depend 2020;213:108090. [PMID: 32559667 DOI: 10.1016/j.drugalcdep.2020.108090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wakeman SE, Kane M, Powell E, Howard S, Shaw C, Regan S. Impact of Inpatient Addiction Consultation on Hospital Readmission. J Gen Intern Med 2021;36:2161-3. [PMID: 32572767 DOI: 10.1007/s11606-020-05966-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Englander H, King C, Nicolaidis C, Collins D, Patten A, Gregg J, Korthuis PT. Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service. J Addict Med 2020;14:415-22. [PMID: 31868830 DOI: 10.1097/ADM.0000000000000611] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 Serota DP, Tookes HE, Hervera B, Gayle BM, Roeck CR, Suarez E, Forrest DW, Kolber MA, Bartholomew TS, Rodriguez AE, Doblecki-Lewis S. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team. Ann Med 2021;53:1960-8. [PMID: 34726095 DOI: 10.1080/07853890.2021.1993326] [Reference Citation Analysis]
5 Chan B, Gean E, Arkhipova-Jenkins I, Gilbert J, Hilgart J, Fiordalisi C, Hubbard K, Brandt I, Stoeger E, Paynter R, Korthuis PT, Guise JM. Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review. J Addict Med 2021;15:74-84. [PMID: 32956162 DOI: 10.1097/ADM.0000000000000739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
6 Weinstein ZM, Cheng DM, D'Amico MJ, Forman LS, Regan D, Yurkovic A, Samet JH, Walley AY. Inpatient addiction consultation and post-discharge 30-day acute care utilization. Drug Alcohol Depend 2020;213:108081. [PMID: 32485657 DOI: 10.1016/j.drugalcdep.2020.108081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hamilton J, Ti L, Korchinski M, Nolan S. Peer Support Specialists: An Underutilized Resource in the Criminal Justice System for Opioid Use Disorder Management? J Addict Med 2022;16:132-4. [PMID: 35289772 DOI: 10.1097/ADM.0000000000000866] [Reference Citation Analysis]
8 Chang JE, Franz B, Cronin CE, Lindenfeld Z, Lai AY, Pagán JA. Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment. Journal of Substance Abuse Treatment 2022. [DOI: 10.1016/j.jsat.2022.108719] [Reference Citation Analysis]
9 Thompson HM, Faig W, VanKim NA, Sharma B, Afshar M, Karnik NS. Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service. PLoS One 2020;15:e0239761. [PMID: 33035229 DOI: 10.1371/journal.pone.0239761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 French R, Aronowitz SV, Brooks Carthon JM, Schmidt HD, Compton P. Interventions for hospitalized medical and surgical patients with opioid use disorder: A systematic review. Subst Abus 2021;:1-13. [PMID: 34283698 DOI: 10.1080/08897077.2021.1949663] [Reference Citation Analysis]
11 Brown PCM, Phillipi GM, King C, Tanski M, Sullivan P. Evaluating new paralysis, mortality, and readmission among subgroups of patients with spinal epidural abscess: A latent class analysis. PLoS One 2020;15:e0238853. [PMID: 32915861 DOI: 10.1371/journal.pone.0238853] [Reference Citation Analysis]
12 Suen LW, Makam AN, Snyder HR, Repplinger D, Kushel MB, Martin M, Nguyen OK. National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014-2018. J Gen Intern Med 2021. [PMID: 34518978 DOI: 10.1007/s11606-021-07069-w] [Reference Citation Analysis]
13 Cunningham P, Barnes A, Mohamoud S, Allen L, Talbert J, Jarlenski MP, Kim JY, Gordon AJ, Tang L, Chang CH, Junker S, Mauk R, Ahrens K, Austin AE, Clark S, Mcduffie MJ, Kennedy S, Donohue JM, Burns M. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses? Journal of Substance Abuse Treatment 2022. [DOI: 10.1016/j.jsat.2022.108807] [Reference Citation Analysis]
14 Clifton D, Ivey N, Poley S, O'Regan A, Raman SR, Frascino N, Hamilton S, Setji N. Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder. J Hosp Med 2022. [PMID: 35535562 DOI: 10.1002/jhm.12837] [Reference Citation Analysis]
15 Vega TA, Levander XA, Seaman A, Korthuis PT, Englander H. "Sobriety equals getting rid of hepatitis C": A qualitative study exploring the interplay of substance use disorder and hepatitis C among hospitalized adults. J Subst Abuse Treat 2021;127:108337. [PMID: 34134860 DOI: 10.1016/j.jsat.2021.108337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Brothers TD, Mosseler K, Kirkland S, Melanson P, Barrett L, Webster D. Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis. PLoS One 2022;17:e0263156. [PMID: 35081174 DOI: 10.1371/journal.pone.0263156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Bahji A, Reshetukha T, Newman A, Good L, Gupta P, Haffey S, Gingrich T, Hicks M, Zuoros I, Reid R, Majere R, Fraser S. The Substance Treatment and Recovery Team (START): Measuring the effectiveness and feasibility of an inpatient addiction consult service at an academic general hospital. Gen Hosp Psychiatry 2020;67:160-1. [PMID: 32487492 DOI: 10.1016/j.genhosppsych.2020.05.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Wakeman SE, Kane M, Powell E, Howard S, Shaw C, Kehoe L, Rosen J, Quinlan J, Regan S. A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation. Subst Abus 2021;42:767-74. [PMID: 33270549 DOI: 10.1080/08897077.2020.1846664] [Reference Citation Analysis]
19 Irwin MN, Walkerly A. Role of the pharmacist in acute care interventions for opioid use disorder: A scoping review. J Am Coll Clin Pharm 2022;5:193-202. [DOI: 10.1002/jac5.1547] [Reference Citation Analysis]
20 King C, Nicolaidis C, Korthuis PT, Priest KC, Englander H. Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysis. J Subst Abuse Treat 2020;118:108121. [PMID: 32972645 DOI: 10.1016/j.jsat.2020.108121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 McNeely J, Hamilton L. Screening for Unhealthy Alcohol and Drug Use in General Medicine Settings. Med Clin North Am 2022;106:13-28. [PMID: 34823726 DOI: 10.1016/j.mcna.2021.08.002] [Reference Citation Analysis]
22 Upadhyaya A, Marks LR, Schwarz ES, Liang SY, Durkin MJ, Liss DB. Care cascade for patients with opioid use disorder and serious injection related infections. Toxicol Commun 2021;5:6-10. [PMID: 33733021 DOI: 10.1080/24734306.2020.1869899] [Reference Citation Analysis]
23 Roy PJ, Price R, Choi S, Weinstein ZM, Bernstein E, Cunningham CO, Walley AY. Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge. Drug Alcohol Depend 2021;224:108703. [PMID: 33964730 DOI: 10.1016/j.drugalcdep.2021.108703] [Reference Citation Analysis]
24 Priest KC, Englander H, McCarty D. "Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services. J Subst Abuse Treat 2020;110:59-65. [PMID: 31952629 DOI: 10.1016/j.jsat.2019.12.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Englander H, Jones A, Krawczyk N, Patten A, Roberts T, Korthuis PT, McNeely J. A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews. J Gen Intern Med 2022. [PMID: 35534663 DOI: 10.1007/s11606-022-07618-x] [Reference Citation Analysis]
26 Brothers TD, Fraser J, MacAdam E, Morgan B, Francheville J, Nidumolu A, Cheung C, Hickcox S, Saunders D, O'Donnell T, Genge L, Webster D. Implementation and evaluation of a novel, unofficial, trainee-organized hospital addiction medicine consultation service. Subst Abus 2020;:1-8. [PMID: 33332248 DOI: 10.1080/08897077.2020.1856291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 O'Donnell M, Englander H, Strnad L, Bhamidipati CM, Shalen E, Riquelme PA. Expanding the Team: Optimizing the Multidisciplinary Management of Drug Use-Associated Infective Endocarditis. J Gen Intern Med 2022. [PMID: 35018563 DOI: 10.1007/s11606-021-07313-3] [Reference Citation Analysis]
28 Nguemeni Tiako MJ, Mszar R, Brooks C 2nd, Bin Mahmood SU, Mori M, Vallabhajosyula P, Geirsson A, Weimer MB. Cardiac surgeons' practices and attitudes toward addiction care for patients with substance use disorders. Subst Abus 2021;:1-6. [PMID: 34038333 DOI: 10.1080/08897077.2021.1917475] [Reference Citation Analysis]
29 Calcaterra SL, McBeth L, Keniston AM, Burden M. The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap. J Gen Intern Med 2021. [PMID: 34013473 DOI: 10.1007/s11606-021-06849-8] [Reference Citation Analysis]
30 Levander XA, Vega TA, Seaman A, Korthuis PT, Englander H. Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs. Int J Drug Policy 2021;:103356. [PMID: 34226111 DOI: 10.1016/j.drugpo.2021.103356] [Reference Citation Analysis]
31 Wilson JD, Altieri Dunn SC, Roy P, Joseph E, Klipp S, Liebschutz J. Inpatient Addiction Medicine Consultation Service Impact on Post-discharge Patient Mortality: a Propensity-Matched Analysis. J Gen Intern Med 2022. [PMID: 35076857 DOI: 10.1007/s11606-021-07362-8] [Reference Citation Analysis]
32 Schranz AJ. A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs. Clin Infect Dis 2020;71:572-3. [PMID: 31504337 DOI: 10.1093/cid/ciz875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Goodman CW, Rhodes MA, Thompson BW, Brazell B, Litwin AH. Advancing Best Practices for Hospitalized Patients with a Volunteer Addiction Consult Team. Am J Med 2021:S0002-9343(21)00566-0. [PMID: 34508707 DOI: 10.1016/j.amjmed.2021.07.047] [Reference Citation Analysis]
34 Thakrar AP, Furfaro D, Keller S, Graddy R, Buresh M, Feldman L. A Resident-Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder. J Hosp Med 2021;16:339-44. [PMID: 34129484 DOI: 10.12788/jhm.3544] [Reference Citation Analysis]
35 Alsabbagh MW, Chang F, Cooke M, Elliott SJ, Chen M. National trends in population rates of opioid-related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population-based study. Addiction 2021;116:3482-93. [PMID: 34170044 DOI: 10.1111/add.15571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
36 Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis. J Gen Intern Med 2020;35:2365-74. [PMID: 32291723 DOI: 10.1007/s11606-020-05815-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
37 Byrne KA, Roth PJ, Merchant K, Baginski B, Robinson K, Dumas K, Collie J, Ramsey B, Cull J, Cooper L, Churitch M, Rennert L, Heo M, Jones R. Inpatient link to peer recovery coaching: Results from a pilot randomized control trial. Drug Alcohol Depend 2020;215:108234. [PMID: 32891501 DOI: 10.1016/j.drugalcdep.2020.108234] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Englander H, Patten A, Lockard R, Muller M, Gregg J. Spreading Addictions Care Across Oregon's Rural and Community Hospitals: Mixed-Methods Evaluation of an Interprofessional Telementoring ECHO Program. J Gen Intern Med 2021;36:100-7. [PMID: 32885371 DOI: 10.1007/s11606-020-06175-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
39 Peterson C, Li M, Xu L, Mikosz CA, Luo F. Assessment of Annual Cost of Substance Use Disorder in US Hospitals. JAMA Netw Open 2021;4:e210242. [PMID: 33666661 DOI: 10.1001/jamanetworkopen.2021.0242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 King CA, Cook R, Wheelock H, Korthuis PT, Leahy JM, Goff A, Morris CD, Englander H. Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality. Int J Drug Policy 2021;100:103525. [PMID: 34837879 DOI: 10.1016/j.drugpo.2021.103525] [Reference Citation Analysis]
41 Braithwaite V, Ti L, Fairbairn N, Ahamad K, McLean M, Harrison S, Wood E, Nolan S. Building a hospital-based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Addiction 2021;116:1892-900. [PMID: 33339073 DOI: 10.1111/add.15383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
42 King CA, Englander H, Korthuis PT, Barocas JA, McConnell KJ, Morris CD, Cook R. Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality. PLoS One 2021;16:e0256793. [PMID: 34506517 DOI: 10.1371/journal.pone.0256793] [Reference Citation Analysis]
43 Kimmel SD, Phillips KT, Anderson BJ, Stein MD. Characteristics associated with motivation to stop substance use and improve skin and needle hygiene among hospitalized patients who inject drugs. Subst Abus 2022;43:878-83. [PMID: 35179454 DOI: 10.1080/08897077.2021.2007520] [Reference Citation Analysis]
44 King C, Collins D, Patten A, Nicolaidis C, Englander H. Trust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study. J Addict Med 2021. [PMID: 33577229 DOI: 10.1097/ADM.0000000000000819] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Hoover K, Lockhart S, Callister C, Holtrop JS, Calcaterra SL. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives. J Subst Abuse Treat 2021;:108708. [PMID: 34991950 DOI: 10.1016/j.jsat.2021.108708] [Reference Citation Analysis]
46 Levander XA, Vega TA, Seaman A, Korthuis PT, Englander H. Exploring how hospitalization can alter hepatitis c virus treatment prioritization and trajectories in people who use drugs: A qualitative analysis. Subst Abus 2021;:1-8. [PMID: 34161198 DOI: 10.1080/08897077.2021.1932699] [Reference Citation Analysis]
47 Montalvo C, von Horn A, Lane CE, Weinstein ZM, Sharma M, Suzuki J. Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar Stroke. Harv Rev Psychiatry 2021;29:370-7. [PMID: 34524778 DOI: 10.1097/HRP.0000000000000305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sikka MK, Gore S, Vega T, Strnad L, Gregg J, Englander H. "OPTIONS-DC", a feasible discharge planning conference to expand infection treatment options for people with substance use disorder. BMC Infect Dis 2021;21:772. [PMID: 34372776 DOI: 10.1186/s12879-021-06514-9] [Reference Citation Analysis]
49 Lennox R, Martin L, Brimner C, O'Shea T. Hospital policy as a harm reduction intervention for people who use drugs. Int J Drug Policy 2021;97:103324. [PMID: 34153628 DOI: 10.1016/j.drugpo.2021.103324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kimmel SD, Bazzi AR, Barocas JA. Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities. J Subst Abuse Treat 2020;118:108103. [PMID: 32972644 DOI: 10.1016/j.jsat.2020.108103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Coon SA, Hill LG, Hutchison RW, Arnold LM, Jarrett JB, Ottney AR, Oung AB, Painter NA, Smith MA, Stranges PM, Tran TH, Mcfee Winans AR, Bratberg JP. Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy. J Am Coll Clin Pharm 2020;3:1493-513. [DOI: 10.1002/jac5.1331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
52 Mitchell LM, Milliken A, Montgomery MW, Singh SK, Suzuki J. The Opioid Crisis and the Inpatient Floor: Considering Injection Drug Use in the Management of Infective Endocarditis and Acute Pain. Harv Rev Psychiatry 2020;28:334-40. [PMID: 32453063 DOI: 10.1097/HRP.0000000000000259] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Priest KC, King CA, Englander H, Lovejoy TI, McCarty D. Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis. Subst Abus 2022;43:1251-9. [PMID: 35670778 DOI: 10.1080/08897077.2022.2074601] [Reference Citation Analysis]
54 Crystal S, Nowels M, Samples H, Olfson M, Williams AR, Treitler P. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients. Drug Alcohol Depend 2022;232:109269. [PMID: 35038609 DOI: 10.1016/j.drugalcdep.2022.109269] [Reference Citation Analysis]
55 King C, Vega T, Button D, Nicolaidis C, Gregg J, Englander H. Understanding the impact of the SARS-COV-2 pandemic on hospitalized patients with substance use disorder. PLoS One 2021;16:e0247951. [PMID: 33635926 DOI: 10.1371/journal.pone.0247951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Schlechter C, Hossain R, Emerman CL. Safety of induction at standard doses of buprenorphine for inpatients with opioid use disorder. J Addict Dis 2022;:1-7. [PMID: 35133233 DOI: 10.1080/10550887.2021.1988292] [Reference Citation Analysis]
57 Callister C, Lockhart S, Holtrop JS, Hoover K, Calcaterra SL. Experiences with an addiction consultation service on care provided to hospitalized patients with opioid use disorder: a qualitative study of hospitalists, nurses, pharmacists, and social workers. Subst Abus 2021;:1-8. [PMID: 34666634 DOI: 10.1080/08897077.2021.1975873] [Reference Citation Analysis]
58 Capizzi J, Leahy J, Wheelock H, Garcia J, Strnad L, Sikka M, Englander H, Thomas A, Korthuis PT, Menza TW. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLoS One 2020;15:e0242165. [PMID: 33166363 DOI: 10.1371/journal.pone.0242165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]